Dorman Products (DORM) Falls Short of Q2 Views
Dorman Products (NASDAQ: DORM) reported Q2 EPS of $0.70, $0.04 worse than the analyst estimate of $0.74. Revenue for the quarter came in at $131.6 million versus the consensus estimate of $133.84 million.